Skip to main content
. Author manuscript; available in PMC: 2020 Mar 30.
Published in final edited form as: ChemistrySelect. 2018 Nov 29;3(44):12625–12629. doi: 10.1002/slct.201802475

Table 1.

The minimum inhibitory concentrations (MIC μg mL−1) of platensimycin analogues against S. aureus ATCC 29213, and clinical MSSA and MRSA strains

Compounds S. aureus
ATCC 29213
MRSA MSSA
PTM 1 0.5 1
Linezolid 1 1 1
7b 64 64 32
8 4 4 4
10a 32 16 16
10b 16 16 8
29c 8 8 8